RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo offers hope for Hard-to-Treat lymphoma
Disease control OngoingThis study is testing whether combining two drugs, copanlisib and venetoclax, can help people with a type of blood cancer called diffuse large B-cell lymphoma that has come back or not responded to prior treatments. About 48 adults will take part. The goal is to find the safest d…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 29, 2026 02:37 UTC
-
New hope for lymphoma patients: targeted drug combo shows promise in late-stage trial
Disease control OngoingThis study tests whether adding a targeted drug (polatuzumab vedotin) to standard chemotherapy helps people with diffuse large B-cell lymphoma that has come back or not responded to initial treatment. About 306 adults will receive either the new combo or standard therapy. The goa…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE3 • Sponsor: GWT-TUD GmbH • Aim: Disease control
Last updated Apr 29, 2026 02:37 UTC